Author:
Akl Elie A,Gunukula Sameer,Barba Maddalena,Yosuico Victor E D,van Doormaal Frederiek F,Kuipers Saskia,Middeldorp Saskia,Dickinson Heather O,Bryant Andrew,Schünemann Holger
Reference96 articles.
1. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study;Agnelli;Lancet Oncology,2009
2. A randomized clinical trial of combination chemotherapy with and without low molecular weight heparin in small cell lung cancer;Altinbas;Journal of Thrombosis and Haemostasis,2004
3. Prospective randomized study of epirubicine cyclophosphamide and vincristine combination chemotherapy (CEV): low molecular weight heparin (LMWH) in small cell lung cancer (SCLC);Altynbas,2001
4. Efficiency of cyclophosphamide, epirubicin, vincristine (CEV) +/- low molecular weight heparin (LMWH) in small cell lung cancer (SCLC): preliminary results;Altynbas,2000
5. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS);Kakkar;Journal of Clinical Oncology,2004
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献